Tranexamic Acid Tablet, Film Coated
Product Images NDC 0591-3720

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tranexamic Acid (NDC 0591-3720). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tranexamic Acid Tablets A202093 1

Chemical structure diagram of Tranexamic Acid showing its molecular framework, including a cyclohexane ring bonded to an amino group and a carboxylic acid functional group.*

FDA Label Image

Tranexamic Acid Tablets A202093 2

A line graph showing mean menstrual blood loss (mL) over a treatment period with six cycles and two baseline points. Four data series represent Tranexamic Acid Tablets 3900 mg/day and placebo groups for 3-cycle and 6-cycle studies. The graph tracks changes in blood loss across the baseline and treatment cycles.*

FDA Label Image

Tranexamic Acid Tablets A202093 3

Tranexamic Acid Tablets 650 mg film-coated tablets label from Actavis Pharma, Inc. The label indicates a package containing 30 tablets for oral use, includes dosing information for adult use, storage instructions, and manufacturer details for Teva Pharmaceuticals USA. The NDC number 0591-3720-30 and barcode are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.